“Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S54. doi:10.25251/skin.2.supp.54.